Abstract
Bacterial genetic properties can be readily altered by a range of techniques, for example, when a mixture of recipient bacteria, donor genes, and nano-sized acicular material are stimulated by sliding friction on surface of the hydrogel such as agarose or gellan gum. In this particular case, a phenomenon called the Yoshida effect is responsible. Specially designed apparatus has been developed to investigate this effect in an effort to identify technical applications, such as the quantitative detection of asbestos. Current patents related to plasmid transformation methods for prokaryotes and quantitative detection of environmental asbestos are also presented.
Keywords: Yoshida effect, asbestos, chrysotile, hydrogel, sepiolite, plasmid, prokaryote, sliding friction, transformation
Recent Patents on Biotechnology
Title: Discovery and Application of the Yoshida Effect: Nano-Sized Acicular Materials Enable Penetration of Bacterial Cells by Sliding Friction Force
Volume: 1 Issue: 3
Author(s): Naoto Yoshida
Affiliation:
Keywords: Yoshida effect, asbestos, chrysotile, hydrogel, sepiolite, plasmid, prokaryote, sliding friction, transformation
Abstract: Bacterial genetic properties can be readily altered by a range of techniques, for example, when a mixture of recipient bacteria, donor genes, and nano-sized acicular material are stimulated by sliding friction on surface of the hydrogel such as agarose or gellan gum. In this particular case, a phenomenon called the Yoshida effect is responsible. Specially designed apparatus has been developed to investigate this effect in an effort to identify technical applications, such as the quantitative detection of asbestos. Current patents related to plasmid transformation methods for prokaryotes and quantitative detection of environmental asbestos are also presented.
Export Options
About this article
Cite this article as:
Yoshida Naoto, Discovery and Application of the Yoshida Effect: Nano-Sized Acicular Materials Enable Penetration of Bacterial Cells by Sliding Friction Force, Recent Patents on Biotechnology 2007; 1 (3) . https://dx.doi.org/10.2174/187220807782330147
DOI https://dx.doi.org/10.2174/187220807782330147 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Chlorophyll Catabolite Pheophorbide a as a Photosensitizer for the Photodynamic Therapy
Current Medicinal Chemistry Current Status and Future Directions of Nanoparticulate Strategy for Cancer Immunotherapy
Current Drug Metabolism Acrylamide Induced Toxicity and the Propensity of Phytochemicals in Amelioration: A Review
Central Nervous System Agents in Medicinal Chemistry Blending of Polyethylenimine with a Cationic Polyurethane Greatly Enhances Both DNA Delivery Efficacy and Reduces the Overall Cytotoxicity
Current Pharmaceutical Biotechnology Signal Transduction Therapy Targeting Apoptosis Pathways in Cancers
Current Signal Transduction Therapy Analytical Methods for Metallothionein Detection
Current Analytical Chemistry PDGF-D Signaling: A Novel Target in Cancer Therapy
Current Drug Targets The Role of Pemetrexed in Lung Adenocarcinoma, Mixed Subtype with Bronchioloalveolar Carcinoma Features
Current Drug Targets Clinical Applications of Cardiovascular Magnetic Resonance
Current Pharmaceutical Design Cross Talk between the Cardiovascular and Nervous Systems:Neurotrophic Effects of Vascular Endothelial Growth Factor (VEGF) and Angiogenic Effects of Nerve Growth Factor (NGF)-Implications in Drug Development
Current Pharmaceutical Design Will Antiangiogenic Agents be a Future for Mesothelioma Therapy?
Current Medicinal Chemistry Bcl-2 Inhibitors: Emerging Drugs in Cancer Therapy
Current Medicinal Chemistry mRNA as a Versatile Tool for Exogenous Protein Expression
Current Gene Therapy Inhibition of RET Activated Pathways: Novel Strategies for Therapeutic Intervention in Human Cancers
Current Pharmaceutical Design Exosomes: The Messengers of Health and Disease
Current Neuropharmacology Effects of Specific Cyclooxygenase-2 Inhibitors on Carcinogenesis
Medicinal Chemistry Reviews - Online (Discontinued) Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Metallodrugs in Targeted Cancer Therapeutics: Aiming at Chemoresistance- related Patterns and Immunosuppressive Tumor Networks
Current Medicinal Chemistry To Seek Shelter from the Wnt in Osteoarthritis? Wnt-Signaling as a Target for Osteoarthritis Therapy
Current Drug Targets Farnesylated Proteins as Anticancer Drug Targets: From Laboratory to the Clinic
Current Medicinal Chemistry - Anti-Cancer Agents